Innsbruck- April 19 2012. UAE-based physicians will present information about their experiences with MED-EL Hearing Implant Systems at the 9th Annual Middle East Update in Otolaryngology Conference and Exhibition (ME-OTO) taking place in Dubai next week (22-24 April 2012).
Dr. Tarabichi, Head of ENT Department, American Hospital Dubai, and Co-Chairman of the conference will moderate a session on the first day of the conference entitled "Cochlear Implants: The next Step" and talk about hearing preservation.
"Cochlear Implants have had a profound effect on the way we treat people with hearing loss or impairment," said Dr. Tarabichi,. "We now have extensive experience with these devices in the UAE and we are able to significantly enhance the lives of these patients."
Prof. Dr. Hammad Mondy, Consultant and Head of ENT Department, Al Mafraq Hospital will also moderate a session on day one about "CI in the Middle East" during which he will present information on "Our Experience in the New MED-EL electrode (FLEX28) for Infants and Young children."
"Cochlear Implant technology continues to evolve," said Prof. Mondy. "It is very important for physicians to share their personal experiences as the technology develops to enable the community to adopt new developments that will enhance the patient experience and results."
This session will represent the first time that information about the FLEX 28 electrode has been presented in the region. The FLEX 28 is a new electrode that is designed for best possible hearing performance while protecting the delicate neural structures during insertion.
About MED-EL
Innsbruck-based MED-EL Medical Electronics is a leading provider of hearing implant systems worldwide. The family-owned business is one of the pioneers in the industry. The two Austrian scientists Ingeborg and Erwin Hochmair developed the world's first microelectronic-multichannel Cochlear-Implant in 1977. The cochlear implant was and remains the first replacement of a human sense, the sense of hearing. In 1990 they laid the foundation for the successful growth of the company when they hired their first employees.
Today, MED-EL offers the widest range of implantable solutions worldwide to treat various degrees of hearing loss: Cochlear and Middle Ear Implant Systems, EAS (combined Electric Acoustic Stimulation) Hearing Implant System and Auditory Brainstem Implants. MED-EL employs some 1,000 people at 28 branches all over the world. Today, tens of thousands of people in more than 96 countries enjoy the gift of hearing with the help of a product from MED-EL. MED-EL's mission is to eliminate hearing loss as a barrier to communication. MED-EL opens up a world of sound to people all around the world, significantly increasing their quality of life. www.medel.com
Responsible for the contentMED-EL Elektromedizinische Geräte Gesellschaft m.b.H.
Fürstenweg 77a
6020 Innsbruck, Österreich
Tel.: +43 (0)512 28 88 89
office@medel.com
Register-Nr. FN 48608h
UST.-ID-NUMMER: ATU 31722507
Press contact
Tom Conway-Gordon
Impact Porter Novelli PR, Dubai
+971 (0)50 954 7854
t.conway-gordon@ipn.ae
© Press Release 2012
